Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Search
Start for free
Markets
/
Stocks
/
vor
/
Vor Biopharma Inc
VOR
Add to Watchlist
21.150
USD
-0.650
-2.98%
Close 07-31 16:00(ET)
Quotes delayed by 15 min
21.470
USD
+21.470
After-hours 08/03, 20:00 (ET)
1.15B
Market Cap
Loss
P/E TTM
Vor Biopharma Inc
21.150
-0.650
-2.98%
Overview
Financials
Discussions
Analysis
Company
Profile
Shareholders
Corporate
Overview
Financials
Discussions
Analysis
Company
Profile
Shareholders
Corporate
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
TCG Crossover Management, LLC
10.47%
Forbion Capital Partners
6.68%
Frazier Life Sciences Management, L.P.
4.69%
Fidelity Management & Research Company LLC
4.66%
RA Capital Management, LP
4.43%
Other
69.07%
Shareholders
Shareholders
Proportion
TCG Crossover Management, LLC
10.47%
Forbion Capital Partners
6.68%
Frazier Life Sciences Management, L.P.
4.69%
Fidelity Management & Research Company LLC
4.66%
RA Capital Management, LP
4.43%
Other
69.07%
Shareholder Types
Shareholders
Proportion
Investment Advisor
19.82%
Venture Capital
15.11%
Hedge Fund
10.96%
Private Equity
4.69%
Corporation
4.16%
Investment Advisor/Hedge Fund
3.32%
Research Firm
0.49%
Bank and Trust
0.13%
Pension Fund
0.04%
Other
41.28%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
192
33.33M
62.59%
+23.59M
2025Q4
164
16.48M
39.69%
+12.43M
2025Q3
155
2.91M
42.56%
-894.32K
2025Q2
165
100.29M
80.27%
+23.22M
2025Q1
174
100.82M
80.73%
+21.38M
2024Q4
172
101.57M
81.78%
+39.14M
2024Q3
175
49.60M
72.03%
-12.93M
2024Q2
174
56.25M
82.04%
-8.25M
2024Q1
168
60.63M
88.57%
-4.75M
2023Q4
163
60.90M
89.54%
-3.77M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Forbion Capital Partners
3.62M
7.41%
+3.24M
+852.84%
Dec 31, 2025
Frazier Life Sciences Management, L.P.
2.54M
5.21%
+2.54M
--
Dec 31, 2025
Fidelity Management & Research Company LLC
2.52M
5.16%
+2.29M
+982.84%
Dec 31, 2025
RA Capital Management, LP
5.41M
11.08%
+6.77K
+0.13%
Mar 12, 2026
VR Adviser, LLC
1.94M
3.98%
+1.44M
+288.78%
Dec 31, 2025
Paradigm BioCapital Advisors LP
1.75M
3.58%
--
--
Dec 31, 2025
Great Point Partners, LLC
1.37M
2.8%
+1.37M
--
Dec 31, 2025
Reprogrammed Interchange LLC
1.17M
2.39%
-472.15K
-28.81%
Oct 21, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares Health Innovation Active ETF
0.17%
iShares Russell 2000 ETF
0%
Global X Russell 2000 ETF
0%
iShares Russell 2000 Value ETF
0%
Global X Russell 2000 Covered Call ETF
0%
ProShares Hedge Replication ETF
0%
Proshares Ultra Russell 2000
0%
DFA Dimensional US Core Equity Market ETF
0%
DFA Dimensional US Sustainability Core 1 ETF
0%
Dimensional US Core Equity 1 ETF
0%
View more
iShares Health Innovation Active ETF
Proportion
0.17%
iShares Russell 2000 ETF
Proportion
0%
Global X Russell 2000 ETF
Proportion
0%
iShares Russell 2000 Value ETF
Proportion
0%
Global X Russell 2000 Covered Call ETF
Proportion
0%
ProShares Hedge Replication ETF
Proportion
0%
Proshares Ultra Russell 2000
Proportion
0%
DFA Dimensional US Core Equity Market ETF
Proportion
0%
DFA Dimensional US Sustainability Core 1 ETF
Proportion
0%
Dimensional US Core Equity 1 ETF
Proportion
0%